SM

Sudha Mittal

Active Director Director DIN 10512880
DIN 10512880 First appointment Feb 2024 Primary industry Manufacturing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudha Mittal

Data last updated:

Sudha Mittal is a Director at Maxlink Stonex Private Limited (since 2024) and Director at Healthvista Pharma Private Limited (since 2024). The companies operate in Manufacturing and Paper.

DIN 10512880
Primary Designation Director
Industry Manufacturing
First Appointment 18 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxlink Stonex Private Limited U46900RJ2024PTC094835
Director29 May 20242024Active
Healthvista Pharma Private Limited U21003RJ2024PTC092766
Director18 Feb 20242024Active

Board colleagues of Sudha Mittal

Directorship timeline

Open interactive timeline →
Maxlink Stonex Private Limited
Healthvista Pharma Private Limited
Premium access

Shareholding and investment profile for Sudha Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudha Mittal

Sudha Mittal currently holds 2 directorships: Maxlink Stonex Private Limited (Director, since 29 May 2024); Healthvista Pharma Private Limited (Director, since 18 Feb 2024).

Sudha Mittal was first appointed on 18 Feb 2024 as Director at Healthvista Pharma Private Limited.

The current boards of Sudha Mittal's companies include Nalin Gupta (Maxlink Stonex Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available